en

PRODUCT DETAIL

Dagrafors 5 mg filmom obalené tablety

Code 6403E
MA number 18/0120/24-S
Product Form: tbl flm 28x1x5 mg (blis.OPA/Al/PVC/Al) - kalend.bal. - jednotk.bal.
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
A10BK01 Dapagliflozin
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 31.05.2024
Validity: 31.05.2029
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL Dagrafors_05.2024.pdf  
SPC: SPC Dagrafors_05.2024.pdf  
Safety feature Yes
Data update: 05.06.2024
eu-flag.png sk-flag.png